Gaudium IVF and Women Health Ltd

Gaudium IVF Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gaudium IVF and Women Health Ltd

₹ 76.5 -2.91%
02 Apr - close price
Company website BSE: 544709 NSE: GAUDIUMIVF
About

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]

Key Points

Business Profile[1][2]
The company operates in the Assisted Reproductive Technology (ART) and IVF segment in India, following a hub-and-spoke model across 30+ locations (7 hubs and 28 spokes). It also runs a 15-bed day-care hospital in Janakpuri (Delhi NCR) and operates an in-house pharmacy through its wholly owned subsidiary, Gaudium International Pvt. Ltd.

Website BSE NSE
  • Market Cap ₹ 557 Cr.
  • Current Price ₹ 76.5
  • High / Low ₹ 99.8 / 69.2
  • Stock P/E 28.8
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 48.6 %
  • ROE 52.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 55.4%

Cons

  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2024 Sep 2025 Dec 2025
14.42 31.73 24.51
8.76 17.96 17.95
Operating Profit 5.66 13.77 6.56
OPM % 39.25% 43.40% 26.76%
0.00 0.15 0.10
Interest 0.39 0.51 1.20
Depreciation 0.58 0.61 0.49
Profit before tax 4.69 12.80 4.97
Tax % 27.72% 26.64% 26.96%
3.40 9.38 3.63
EPS in Rs 0.55 1.53 0.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
37 44 48 71
23 24 28 42
Operating Profit 14 20 19 29
OPM % 37% 46% 41% 41%
0 0 0 0
Interest 1 0 1 2
Depreciation 1 1 2 2
Profit before tax 12 18 17 25
Tax % 26% 26% 38% 25%
9 14 10 19
EPS in Rs 89.17 136.54 104.22 3.12
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 25%
TTM: 48%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 29%
TTM: 85%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 55%
Last Year: 52%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.99 0.99 0.99 31 31
Reserves 8 22 26 16 28
6 12 17 21 24
3 2 7 22 24
Total Liabilities 18 37 51 89 107
4 18 19 18 30
CWIP 0 0 0 7 0
Investments 0 0 0 5 5
14 18 32 58 72
Total Assets 18 37 51 89 107

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1 24 3 9
-1 -16 -5 -15
3 5 -1 2
Net Cash Flow 0 13 -3 -5
Free Cash Flow -2 9 1 -0
CFO/OP 13% 141% 27% 46%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65 8 104 170
Inventory Days 29 111 168 175
Days Payable 114 77 62 338
Cash Conversion Cycle -20 41 210 7
Working Capital Days 61 -52 -15 44
ROCE % 76% 45% 49%

Shareholding Pattern

Numbers in percentages

5 Recently
Feb 2026
71.29%
9.24%
5.11%
14.36%
No. of Shareholders 39,883

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP